§ 520.370 Cefpodoxime tablets.
Primary source
Verbatim text below is from the Electronic Code of Federal Regulations (eCFR), a public-domain U.S. government work. Always verify the current version with the eCFR before relying on it for any legal matter.
Full Text
Specifications.(a) (1) Each tablet contains cefpodoxime proxetil equivalent to 100 or 200 milligrams (mg) cefpodoxime.
(2) Each chewable tablet contains cefpodoxime proxetil equivalent to 100 or 200 mg cefpodoxime.
Sponsors.(b) See sponsors in § 510.600(c) of this chapter for uses as follows:
(1) Nos. 017033 and 086101 for use of product in paragraph (a)(1) of this section as in paragraph (c) of this section.
(2) No. 054771 for use of products in paragraph (a) of this section as in paragraph (c) of this section.
Conditions of use in dogsAmount.(c) —(1) 5 to 10 mg per kilogram (2.3 to 4.5 mg per pound) body weight daily for 5 to 7 days, or for 2 to 3 days beyond the cessation of clinical signs, up to a maximum of 28 days.
Indications for use.Staphylococcus pseudintermediusS. aureusStreptococcus canisEscherichia coliPasteurella multocidaProteus mirabilis.(2) For the treatment of skin infections (wounds and abscesses) caused by susceptible strains of , , (group G, beta-hemolytic), , , and
Limitations.(3) Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[69 FR 52815, Aug. 30, 2004, as amended at 78 FR 5714, Jan. 28, 2013; 79 FR 28819, May 20, 2014; 80 FR 13229, Mar. 13, 2015; 82 FR 12169, Mar. 1, 2017; 88 FR 16547, Mar. 20, 2023; 91 FR 5300, Feb. 6, 2026]
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.